详细信息
- ;CAL101 IDELALISIB N-2中间体;(S)-叔丁基-1-(5-氟-4-氧代-3-苯基-3,4-二氢喹唑啉-2-基)丙基;[(1S)-1-(5-氟-3,4-二氢-4-氧代-3-苯基-2-喹唑啉基)丙基氨基酸叔丁基酯;Idelalisib中间体3;二氢-4-氧代-3-苯基-2-喹唑啉基)丙基]氨基甲酸叔丁酯;((1S)-1-(5-氟-3,4-二氢-4-氧代-3-苯基-2-喹唑啉基)丙基)氨基甲酸叔丁酯;
- Carbamic acid,[(1S)-1-(5-fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]-,1,1-dimethylethyl ester
- ;idelalisib N-2;(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate;Idelalisib Intermediate-3;((1s)-1-(5-fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl)carbamicacid1,1-dimethylethyl ester;(S)-tert-butyl(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl) carbaMate;
- CAS NO：870281-85-9
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。